옵션 체인은 다양한 행사가격과 만기일에 대한 Candel Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Candel Therapeutics에 대한 시장 심리를 평가합니다..

Candel Therapeutics (NASDAQ:CADL) 주식, 옵션 체인

Candel Therapeutics

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Equities

News

Markets

CADL

NVDA

PLTR

TSLA

미국 주식 시장은 목요일에 하락하며, 다우존스 지수는 1.35% 하락한 38,596.98에 도달했다. NASDAQ와 S&amp;P 500도 각각 1.4% 하락한 16,049.08과 1.23% 하락한 5,147.21을 기록했다. 전체 시장의 하락에도 불구하고, 일부 종목은 소매 트레이더와 투자자들의 주목을 끌었다.



하루 내내 소매 트레이더와 투자자들의 관심을 끌은 주요 주식은 다음과

목요일의 주요 주식: 포드, 캔들 테라퓨틱스, 엔비디아, 팔란티어, 테슬라

Candel Therapeutics Inc

Cadeler AS

Leading cryptocurrencies jumped as polls began to close in the high-stakes presidential election between Donald Trump and Kamala Harris.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 8:30 p.m. EDT)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>+4.68%</td>
<td>$71,154.46</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+2.23%</td>
<td>$2,460.12</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+8.20%</td>
<td>$0.1763</td>
</tr>
</tbody>
</table>
</figure>
What Happened: After days of retracement, Bitcoin got back in the groove as it breached the $71,000 level. The leading cryptocurrency was just 3.8% away from its all-time high of $73,737.
Ethereum also approached $2,500, while Dogecoin, the king of joke coins, surged by more than 8% as election results began to come in.
Trump was leading in the battleground states of Georgia and Florida, resulting in his <a href="https://polymarket.com/event/presidential-election-winner-2024?tid=1730855062824">odds </a>on Polymarket shooting to 72%.&nbsp;
Ethereum also encountered heavy sell-offs, while Dogecoin outperformed the market with over 8% gains in the last 24 hours.
Short sellers suffered as more than $133 million in bearish bets were wiped out due to the rally.&nbsp;
Bitcoin's Open Interest spiked 3.70%, while top traders on the cryptocurrency exchange Binance remained bullishly positioned for the coin.&nbsp;
Market participants remained "Greedy," as per the Cryptocurrency Fear and Greed Index.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 8:45 p.m. EDT)</td>
</tr>
<tr>
<td>Artificial Superintelligence Alliance(FET)</td>
<td>+1.27%</td>
<td>$0.1633</td>
</tr>
<tr>
<td>Cat in a dogs world (MEW)</td>
<td>+11.44%</td>
<td>$0.008809</td>
</tr>
<tr>
<td>Bittensor (TAO)</td>
<td>+10.59%</td>
<td>$469.17</td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency stood at $2.34 trillion, following a spike of 5.22% in the last 24 hours.
Stocks surged sharply Tuesday in anticipation of the results. The Dow Jones Industrial Average gained 427.28 points, or 1.02%, to close at 42,221.88. The S&amp;P 500 jumped 1.23% to end at 5,782.76, while the tech-focused Nasdaq Composite closed 1.43% higher at 18,439.17.
Stock futures also ascended in anticipation, with those linked to the Dow popping more than 300 points overnight.
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: Widely followed cryptocurrency analyst Michaël van de Poppe noted Bitcoin's move above $71,000 amid Trump's lead in the battleground states of Virginia and Florida.
"This might not be as tight as it was expected. This might also be the kickstart of the bull market + a weak labor market," the analyst predicted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> breaking $70K and makes a new high, as Trump takes a significant lead in Georgia, Florida, Virginia and South Carolina. This might not be as tight as it was expected. This might also be the kickstart of the bull market + a weak labor market.
&mdash; Michaël van de Poppe (@CryptoMichNL) <a href="https://twitter.com/CryptoMichNL/status/1853958629365289455?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
However, indications of profit-taking by whales also surfaced after influential analyst Ali Martinez drew attention to the sharp drop in addresses holding more than 1,000 BTCs leading up to the election.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> whales are dialing back exposure ahead of the U.S. elections, with a 2% drop in addresses holding over 1,000 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>. <a href="https://t.co/rlq6Y5YJ93">pic.twitter.com/rlq6Y5YJ93</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1853777283061850450?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41754690/worlds-largest-political-bettor-gives-donald-trump-a-90-chance-of-winning-election-citing-">World&#8217;s Largest Political Bettor Gives Donald Trump A 90% Chance Of Winning Election, Citing &#8216;Real&#8217; Numbers</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

Trading Ideas

$BTC

$DOGE

$ETH

Bitcoin Hits $71K, Ethereum, Dogecoin Surge As Results Trickle In For Trump-Harris Presidential Battle: Analyst Predicts 'Kickstart Of The Bull Market'

Florida voters rejected an initiative to legalize marijuana for adult use. Known as Amendment 3, the initiative did not garner the 60% votes necessary Tuesday to pass a constitutional amendment though it did get a clear majority.
The initiative enjoyed star-studded endorsements, including from <a href="https://www.benzinga.com/markets/cannabis/24/08/40666944/donald-trump-supports-cannabis-legalization-in-florida-game-changer-and-huge-blow-to-ron-desanti">former President Donald Trump</a>, who is a Florida resident. But it faced tough and sustained GOP opposition from Gov. <a href="https://www.benzinga.com/topic/ron-desantis" target="_blank" rel="noreferrer noopener">Ron DeSantis</a> and the Florida Republican Party.
With 93% of votes counted, the amendment failed with 55.8% yes votes and 44.2% no votes, according to the Associated Press.
Smart &amp; Safe Florida, the campaign that got the initiative onto the ballot, put out a notice shortly after receiving the news.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/O7X6zHZEY0">pic.twitter.com/O7X6zHZEY0</a>
&mdash; Smart &amp; Safe Florida (@SmartandSafeFl) <a href="https://twitter.com/SmartandSafeFl/status/1853974758641049896?ref_src=twsrc%5Etfw">November 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In the weeks before Election Day, DeSantis held a string of conferences denouncing the amendment. Campaign groups opposing legalization were essentially staffed by DeSantis allies. In what many called misusing public money, the Florida <a href="https://www.benzinga.com/markets/cannabis/24/09/41036799/desantis-provokes-outrage-over-taxpayer-funded-ads-linking-marijuana-legalization-to-car-crashes">transportation department ran ads</a> saying that DUI crashes increased in states with legal marijuana, which caused the Amendment 3 campaign to send out cease-and-desist notices.
<h2 class="wp-block-heading">Cannabis Industry Responds</h2>
"While it's disappointing to see Florida's Amendment 3 fall short of the 60% threshold necessary, it's important to recognize the bipartisan voter support that the measure received," said Anthony Coniglio, CEO of <a href="https://newlake.com/" target="_blank" rel="noreferrer noopener">NewLake Capital Partners, Inc</a>. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NLCP#OTC">NLCP</a>). 
"Constitutional amendments requiring 60% approval are always difficult but Americans&#8217; support for the cannabis industry is undeniable. These results don't erase the progress the sector has made or the growing public support for cannabis nationwide."
Tyler Beuerlein, business development officer at Safe Harbor Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>), acknowledged that state-level changes do not automatically resolve broader industry challenges.
"Despite both major political parties now voicing support for cannabis reform, federal legalization remains complex, with numerous unresolved issues around banking, interstate commerce, and comprehensive regulatory frameworks."
<ul>
<li>Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41755971/desantis-on-wrong-side-of-history-curaleaf-chair-says-as-governor-calls-trulieve-big-pharma-on-s">DeSantis &#8216;On Wrong Side Of History,&#8217; Curaleaf Chair Says: Governor Calls Trulieve &#8216;Big Pharma On Steroids&#8217;</a></li>
</ul>
Illustration created using artificial intelligence.

Cannabis

Government

Politics

Legal

NLCP

SHF Holdings, Inc. - Class A Common Stock

SHFS

Florida Rejects Cannabis Legalization Amendment Supported By Trump, Detested By DeSantis

On Election Day 2024, major U.S. indices ended on a positive note. As the election results began rolling in, Dow Futures jumped nearly 400 points. 
For the day, the Dow Jones Industrial Average rose 1.02% to close at 42,221.88, the S&amp;P 500 increased 1.23% to 5,782.76, and the Nasdaq climbed 1.4% to 18,439.17.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>)
Trump Media&#8217;s stock saw a significant surge, closing the day with a decrease of 1.16% at $33.94. The stock&#8217;s intraday high and low were $40.74 and $31.45 respectively, with a 52-week range of $79.38 to $22.55. The <a href="https://www.benzinga.com/news/24/11/41763035/trump-media-stock-shoots-up-over-10-in-after-market-trading-as-ex-president-scores-victories-in-kent">substantial increase</a> in Trump Media's stock in the after-hours is driven by the ongoing U.S. elections and the third-quarter financial results.
Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>)
Reddit&#8217;s stock closed the day with an increase of 12.58% at $122.57. The stock&#8217;s intraday high and low were $122.68 and $110.27 respectively, with a 52-week range of $123.6 to $37.35. Election day saw voters visiting polling locations and social media mavens <a href="https://www.benzinga.com/news/24/11/41761596/redditors-track-election-night-must-watch-threads-for-trump-vs-harris-showdown-other-races">sharing opinions</a> and local reports in megathreads, polls and comments on Reddit.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41704760/bitcoin-ethereum-dogecoin-reverse-as-trumps-odds-fall-on-betting-markets-trader-says-bull-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Reverse As Trump&#8217;s Odds Fall On Betting Markets: Trader Says &#8216;Bull Run Will Begin&#8217; For This Crypto After The Election</a>
Devon Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>)
Devon Energy&#8217;s stock closed the day with an increase of 0.51% at $39.34. The stock&#8217;s intraday high and low were $39.59 and $38.79 respectively, with a 52-week range of $55.09 to $37.77. The company reported <a href="https://www.benzinga.com/news/earnings/24/11/41762517/devon-energy-q3-earnings-eps-beat-production-forecast-raise-and-more">third-quarter earnings</a> of $1.30 per share, beating analyst estimates of $1.14 per share.
Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
Super Micro Computer&#8217;s stock closed the day with an increase of 6.42% at $27.70. The stock&#8217;s intraday high and low were $28 and $25.1 respectively, with a 52-week range of $122.9 to $23.9. The company&#8217;s stock <a href="https://www.benzinga.com/news/earnings/24/11/41750022/super-micro-computer-stock-is-in-the-spotlight-ahead-of-q1-earnings-whats-going-on">bounced back</a> after falling nearly 50% last week after the firm's independent auditor raised governance and transparency concerns. Super Micro Computer faced intense scrutiny ahead of its first-quarter earnings, with shares down amid governance issues, a key auditor's exit, and risks to its <a href="https://www.benzinga.com/trading-ideas/technicals/24/11/41745935/super-micro-computer-posts-q1-earnings-are-delisting-fears-here-to-stay-or-can-the-stock">partnership with Nvidia</a>. Analysts remain cautious, citing transparency concerns and potential Nasdaq delisting.
Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s stock closed the day with an increase of 3.54% at $251.44. The stock&#8217;s intraday high and low were $255.28 and $246.21 respectively, with a 52-week range of $273.54 to $138.8. CEO Elon Musk <a href="https://www.benzinga.com/news/24/11/41738613/elon-musk-rejects-rumors-of-a-tesla-phone-but-says-the-ev-giant-will-have-to-make-one-if-this-happen">refuted rumors</a> that the company is considering building a phone.
Prepare for the day&#8217;s trading <a href="Premarket Movers &amp; News">with top premarket movers and news</a> by Benzinga.
Image via Shutterstock
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734072/bitcoin-ethereum-slip-while-dogecoin-surges-ahead-of-presidential-election-analyst-predict?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum Slip While Dogecoin Surges Ahead Of Presidential Election; Analyst Predicts BTC Will Hit $100K+ Regardless Of Trump Or Harris Win</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

RDDT

SMCI

Trump Media, Reddit, Devon Energy, Super Micro Computer, And Tesla Buzzing Among Investors On Election Day

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) executive chair Jeff Bezos has sold off a significant chunk of his Amazon shares, according to a filing with the U.S. Securities and Exchange Commission.
What Happened: Bezos recently divested 1.07 million shares of Amazon stock at $200.07 per share, raking in approximately $213.8 million. As per the SEC filing on Tuesday, this transaction leaves Bezos with 926.41 million shares of the e-commerce giant.
Bezos isn&#8217;t the only Amazon insider to have sold shares recently. Director Jonathan Rubinstein also offloaded $1 million worth of shares, while Douglas Herrington, CEO of Worldwide Amazon Stores, sold $696,360 worth of Amazon shares.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41734887/cathie-woods-latest-shake-up-dumps-palantir-and-jack-dorseys-block-along-with-tesla-buys-amazon-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">DJT Stock Volatile On Election Day: Donald Trump&#8217;s Media Company Reports Q3 Earnings, Growth Initiatives</a>
Why It Matters: Amazon&#8217;s stock remains a compelling investment opportunity, according to Bernstein analyst Mark Shmulik. Shmulik maintained an &#8220;Outperform&#8221; rating on the stock with a $235 price target, citing Amazon&#8217;s promising future despite <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41737293/amazon-stock-buy-now-pay-off-later-says-analyst">planned infrastructure spending</a>.
Amazon&#8217;s strong performance has also attracted the attention of prominent investor Cathie Wood, who recently <a href="https://www.benzinga.com/markets/equities/24/11/41734887/cathie-woods-latest-shake-up-dumps-palantir-and-jack-dorseys-block-along-with-tesla-buys-amazon-">made significant trades</a> in the company&#8217;s stock. 
The company recently reported third-quarter net sales of $158.9 billion, surpassing expectations and marking an 11% increase from the previous year. This positive performance has contributed to a rise in Amazon&#8217;s stock price, which saw a significant uptick <a href="https://www.benzinga.com/news/24/11/41688665/amazon-posts-upbeat-results-joins-cardinal-health-waters-atlassian-charter-communications-mastec-and">following the earnings announcement</a>.
Price Action: Amazon stock closed at $199.50 on Tuesday, rising by 1.90% during the day. In after-hours trading, the stock dipped 0.20%. Year-to-date, Amazon&#8217;s stock has seen substantial growth, up by 33.06%, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41734592/palantir-trump-media-hims-hers-health-nxp-semiconductors-and-tesla-why-these-5-stocks-are-on-inv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">PLTR, DJT, HIMS, NXPI, TSLA: Top 5 Trending Stocks Today</a></li>
</ul>
Image via Flickr/ Daniel Oberhaus
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Global

AMZN

Jeff Bezos Sells $214M Worth Of Amazon Shares In Latest Stock Move, Here's How Much He Still Owns

As polls begin to close for <a href="https://www.benzinga.com/news/24/11/41762845/trump-wins-kentucky-indiana-harris-scores-vermont-as-polls-begin-to-close-across-us">the high-voltage 2024 presidential race</a>, Tesla and SpaceX CEO Elon Musk has revealed his intentions to extend his pro-Trump super PAC beyond the 2024 election.
What Happened: On Tuesday night, during a live session on his social media platform, X, formerly Twitter, Musk announced his plans to now focus on the 2026 midterms and local races.
He suggested that a Trump victory would indicate a public desire for change. &#8220;I think there's a sea change in the country,&#8221; Musk said. &#8220;I hope I'm not wrong about that.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Drag everyone you know to vote!!! <a href="https://t.co/TDwrH01EkA">https://t.co/TDwrH01EkA</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1853949501364383957?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This information was first <a href="https://apnews.com/live/trump-harris-election-updates-11-5-2024">reported</a> by the Associated Press.
See Also: <a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle: &#8216;Doughmacracy For All!&#8217;</a>
Why It Matters: Last month, it was reported that Musk's publicly disclosed political contributions have <a href="https://www.benzinga.com/news/24/10/41561298/elon-musk-pumps-more-than-130m-into-trump-and-gop-campaigns">surpassed $130 million</a>, though the real amount may be greater.
Allegations also surfaced that the tech mogul was financially backing a "dark money" nonprofit, which contributed $3 million to a super PAC airing ads that depict Vice President Kamala Harris in a conflicting light on her stance toward Israel.
However, his political activities have not been without controversy. Musk was <a href="https://www.benzinga.com/news/24/10/41651620/elon-musk-ordered-to-attend-court-hearing-over-1m-election-giveaway">summoned to court over a $1 million lottery</a> organized by his political action committee.
The lawsuit questioned the legality of the lottery, which targeted registered voters in pivotal states.
Meanwhile, Musk has been vocal about his vision for <a href="https://www.benzinga.com/personal-finance/24/11/41701075/elon-musk-warns-of-hardship-for-americans-if-trump-puts-him-in-charge-of-cutting-33-trillion-deb">government efficiency, warning</a> of potential hardship for Americans if Republican candidate Donald Trump appoints him to lead efforts to cut the $33 trillion debt.
Analysts believe a Trump victory could be a potential <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41709990/trump-and-tesla-what-the-future-holds-for-elon-musks-ev-giant-in-case-of-a-gop-win">positive for Musk&#8217;s company Tesla</a>, despite the overall impact on the electric vehicle industry.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41710411/market-analyst-who-predicted-trumps-2016-win-and-bidens-2020-victory-now-sees-former-president-retak?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Market Analyst Who Predicted Trump&#8217;s 2016 Win And Biden&#8217;s 2020 Victory, Now Sees Former President Retaking The White House With &#8216;Large Majority Of Swing States&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Elon Musk Is Already Eyeing 2026 Midterms, Plans To Expand Pro-Trump PAC Beyond Current Election: 'There's A Sea Change In The Country'

PoltiFi tokens and non-fungible tokens (NFTs) inspired by former President Donald Trump took flight as the GOP nominee gained the upper hand in key battleground states.
What happened: Maga, the largest of all Trump-themed coins, shot up 21% in the last 24 hours to a market capitalization of $185 million, <a href="https://www.coingecko.com/en/categories/politifi">according</a> to CoinGecko.
Doland Tremp, parodying the former president&#8217;s name, swelled nearly 40%, while Maga Hat ballooned to 21%.&nbsp;
Interestingly, despite having a lower market cap, MAGA clocked higher trading volume than TRUMP.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 8:23 p.m. ET)</td>
</tr>
<tr>
<td>Doland Tremp (TREMP)</td>
<td>+39.6%</td>
<td>$0.4114</td>
</tr>
<tr>
<td>Maga Hat (MAGA)</td>
<td>+21.1%</td>
<td>$0.0001982</td>
</tr>
<tr>
<td>Maga (TRUMP)</td>
<td>+18.4%</td>
<td>$4.11</td>
</tr>
<tr>
<td>Trump 47 (47)</td>
<td>+11.2%</td>
<td>$0.01437</td>
</tr>
</tbody>
</table>
</figure>
In contrast, Kamala Horris (KAMA), a coin themed around Vice President Kamala Harris, tumbled over 13% in the last 24 hours.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41752969/nate-silvers-closest-call-yet-how-2024s-election-stands-apart-from-his-predictions-in-2016">Nate Silver&#8217;s Closest Call Yet: How 2024&#8217;s Election Stands Apart From His Predictions In 2016 And 2020</a>
Trump's NFT collections also received a boost. The latest of his digital cards, "America First Edition," saw its floor price increase 5% in the last 24 hours, <a href="https://nftpricefloor.com/trump-digital-trading-cards-america-first-edition">according </a>to NFT Price Floor.
The "Mugshot Edition," launched in Dec. 2023, was up 2.94%.&nbsp;
For the uninitiated, the floor price of an NFT is the lowest price at which an NFT in a collection can be purchased. It&#8217;s a key metric for buyers to understand the market value and accessibility of a collection.
The spike in Trump-associated cryptocurrencies came as the Republican hopeful <a href="https://www.benzinga.com/news/24/11/41762845/trump-wins-kentucky-indiana-harris-scores-vermont-as-polls-begin-to-close-across-us">won the red states of Kentucky, Florida and Indiana</a>, and was leading in the swing state of Georgia as of this writing.
Image via Flickr
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41756372/robinhoods-election-contracts-hit-200-million-trades-on-election-day">Robinhood&#8217;s Election Contracts Hit 200 Million Trades On Election Day</a></li>
</ul>

Trump-Themed Cryptos, NFTs Surge In Expectations Of Former President's Victory — Coin Inspired By Harris Falls 13%

General

Updated Electoral Vote Count As Of 8:53 p.m. ET: AP Projects Trump With 101 Electoral Votes, Harris With 71 Electoral Votes

AAWH

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

AUSAF

AVTBF

AYRWF

BBRRF

BHHKF

BLOZF

BMMJ

CANN

CBDY

CBMJ

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CHOOF

CLSH

CLVR

CNBS

CNBX

CNGGF

CNPOF

CNTMF

CNVCF

CPHRF

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVHIF

CVSI

CWBHF

CANNIBIS GROWTH OPTY CORP by Cannabis Growth Opportunity Corp.

CWWBF

CXXIF

ELLXF

EMOR

ETST

EVIO

FFLWF

FFNTF

FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc.

FFRMF

FLGC

FLOOF

FLWPF

FINCANNA CAPITAL CORP by Fincanna Capital Corp.

FNNZF

FUAPF

GABRIELLAS KITCHEN INC by Gabriella's Kitchen Inc.

GABLF

GBHPF

GENE

GHBWF

GLASF

GNLN

GRAMF

GRNH

GRWG

GREEN SPIRIT INDUSTRIES by Green Spirit Industries Inc.

GSRX

GTBIF

HBOSF

HEMP

HERTF

HHPHF

HMLSF

IIPR

INCR

INLB

ISODIOL INTERNATIONAL ORD by Isodiol International Inc.

ISOLF

ITHUF

IVITF

JWCAF

KALY

KAYS

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LFCOF

LFLY

LIFD

LMLLF

LNLHF

LOVFF

LRSNF

LVRLF

LXLLF

MAPS

MGCLF

MGWFF

MJNE

MJUS

MMNFF

MPXOF

MRMD

NDVAF

NOBDF

NWVCF

OILFF

PHOT

PKPH

AP Reports Florida Voters Reject Cannabis Legalization; Amendment 3 Did Not Secure 60% Of Vote

As the presidential election between Donald Trump and Kamala Harris comes to its final leg, shares of&nbsp;Trump Media &amp; Technology Group Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) experienced a significant surge.
What Happened: The substantial increase in Trump Media&#8217;s stock is driven by the ongoing&nbsp;U.S. elections and the <a href="https://www.benzinga.com/news/earnings/24/11/41760961/djt-stock-volatile-on-election-day-donald-trumps-media-company-reports-q3-earnings-growth-initiativ">third-quarter financial results</a>.
At the time of writing, the after-hours trading volume for the stock stood at 21.9 million, according to Nasdaq data. The after-hours high for the stock was $49.78, while the low was at $31.12.
Notably, the <a href="https://www.benzinga.com/news/earnings/24/11/41760961/djt-stock-volatile-on-election-day-donald-trumps-media-company-reports-q3-earnings-growth-initiativ">heightened volatility</a> in the shares led to trading being halted twice on Tuesday.
Both Trump and Harris have <a href="https://www.benzinga.com/news/24/11/41762845/trump-wins-kentucky-indiana-harris-scores-vermont-as-polls-begin-to-close-across-us">achieved early victories in traditionally</a>&nbsp;Republican and Democratic states, respectively.&nbsp;Trump prevailed in Kentucky, West Virginia, and Indiana, while Harris secured Vermont.
See Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41712755/jim-cramer-recommends-buying-this-tech-stock-that-is-a-terrific-situation?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jim Cramer Recommends Buying This Tech Stock: &#8216;That Is A Terrific Situation&#8217;</a>
In Kentucky, with 34% of the votes counted, Trump leads with 64.6%. In Indiana, where 24% of the vote has been counted, he holds 64%. Meanwhile, in Vermont, with 20% of votes tallied, Harris is ahead with 69%.
If Harris, 60, is elected, she would make history as the first female president, the first Black woman, and the first&nbsp;person of South Asian descent&nbsp;to hold the office.
Similarly, if Trump, 78, wins he would become the oldest president ever elected and the first president to win another term after a defeat in 132 years.
Traders are viewing Trump's stock as a barometer for his chances in the upcoming election. Should Trump secure victory, his platform, Truth Social, is anticipated to be central to his communication strategy.
A win by Vice President Harris might bring challenges to the future of Truth Social.
Why It Matters: Trump Media &amp; Technology Group&#8217;s stock volatility is not only tied to the election but also to its financial performance.
After the markets closed on Tuesday, the company announced third-quarter net sales of $1.01 million, a 6% decrease year-over-year. All of its revenue came from advertising on the Truth Social platform in the quarter.
The company posted a loss of 10 cents per share, an improvement from the 30 cents per share loss recorded in the third quarter of last year.
&#8220;TMTG&#8217;s success depends in part on the popularity of our brand and the reputation and popularity of President Donald J. Trump. The value of TMTG&#8217;s brand may diminish if the popularity of President Donald J. Trump were to suffer,&#8221; said the company while reporting the financial results.
Trump holds an approximately 57% ownership stake in Trump Media.
Price Action: DJT shares wrapped up Tuesday's session with a 1.16% increase, closing at $33.94. However, in after-hours trading, the company&#8217;s shares surged, and at the time of writing, they jumped 10.43% to reach $37.48, according to <a href="https://pro.benzinga.com/">data from Benzinga Pro.</a>
Photo via Shutterstock.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41734592/palantir-trump-media-hims-hers-health-nxp-semiconductors-and-tesla-why-these-5-stocks-are-on-inv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Palantir, Trump Media, Hims &amp; Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors&#8217; Radars Today</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Trump Media Stock Shoots Up Over 10% In After-Market Trading As Ex-President Scores Victories In Kentucky, Indiana And West Virginia

Macro Economic Events

Economics

2024 Presidential Election Polls Close In AR

Updated Electoral Vote Count As Of 8:20 p.m. ET: AP Projects Trump With 95 Electoral Votes, Harris With 35 Electoral Votes

As polls begin to close on the East Coast for the 2024 presidential election, the nation waits to see if Donald Trump or Kamala Harris will secure a historic victory.
Trump has secured Kentucky and Indiana, while Harris has won Vermont, according to the Associated Press. With 34% of votes counted in Kentucky, Trump leads with 64.6%. In Indiana, with 24% of votes counted, Trump holds 64%. Meanwhile, with 20% of Vermont&#8217;s votes tallied, Harris has 69%.
In Kentucky, Trump received the endorsement of Senate GOP Leader Mitch McConnell (R-Ky.) despite their previous differences over the Jan.6 Capitol Riots, noted AP.
Vermont is considered a Democrat stronghold and the state&#8217;s Republican Governor Phil Scott voted Democrat in this election, according to the report.
Trump&#8217;s former Vice President and former Indiana Governor Mike Pence <a href="https://www.benzinga.com/news/24/03/37764902/no-surprise-former-trump-ally-refuses-to-endorse-ex-president-in-2024-cites-differences-in-conservat">did not endorse</a> him in the 2024 run but the Hoosier State is a reliable GOP stronghold where the party has held the governor&#8217;s office for the past two decades.
West Virginia voted for Trump for the third straight presidential election cycle as well. No democrat has won the presidential election in the state since Bill Clinton in 1996, according to AP.
Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41760961/djt-stock-volatile-on-election-day-donald-trumps-media-company-reports-q3-earnings-growth-initiativ">DJT Stock Volatile On Election Day: Donald Trump&#8217;s Media Company Reports Q3 Earnings, Growth Initiatives</a></li>
</ul>
Image via Wikimedia Commons
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Trump Wins Kentucky, Indiana — Harris Scores Vermont As Polls Begin To Close Across US

<h3 class="wp-block-heading">STOCKS RISES STEADILY ASTER SIGNAL</h3>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="690" height="879" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/05213424/Screen-Shot-2024-11-05-at-4.38.22-PM.png" alt="" class="wp-image-3000" style="width:auto;height:450px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/05213424/Screen-Shot-2024-11-05-at-4.38.22-PM.png 690w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/11/05213424/Screen-Shot-2024-11-05-at-4.38.22-PM-235x300.png 235w" sizes="(max-width: 690px) 100vw, 690px" /></figure>
Atlassian Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:44 AM on November 5th, a significant trading signal occurred for Atlassian Corp as it demonstrated a Power Inflow at a price of $215.68 This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Atlassian&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Atlassian&#8217;s stock price, interpreting this event as a bullish sign.
<h3 class="wp-block-heading">Signal description</h3>
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for TEAM, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
<h3 class="wp-block-heading">After Market Close UPDATE:</h3>
The price at the time of the Power Inflow was $215.68. The returns on the High price ($222.29) and Close price ($221.54) after the Power Inflow were respectively 3.0% and 2.3%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case the high of the day and close were very close but that is not always the case
<h4 class="wp-block-heading">Past Performance Is Not Indicative Of Future Results</h4>

Signals

TEAM

Tradepulse Power Inflow Alert: Atlassian Corp. Class A Receives Alert And Climbs Over 3% On The Day

S&P Futures Move Higher On Volume

Devon Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) reported financial results for the third quarter after the bell on Tuesday. Here&#8217;s a look at the <a href="https://www.benzinga.com/pressreleases/24/11/g41757702/devon-energy-reports-third-quarter-2024-results-and-declares-quarterly-dividend">key metrics from the quarter</a>.
Q3 Earnings: Devon Energy reported third-quarter earnings of $1.30 per share, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $1.14 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Devon said oil production reached 335,000 barrels per day during the quarter, about 4% ahead of the company&#8217;s previous guidance. 
The company said it generated $1.7 billion in operating cash flow and $786 million in free cash flow during the quarter before returning $431 million to shareholders. Devon repurchased $295 million of its common stock in the quarter and declared a fixed quarterly cash dividend of 22 cents per share, payable on Dec. 30 to shareholders of record as of Dec. 13.
&#8220;The Delaware Basin continues to be a great contributor to our success. The exceptional well productivity and cycle time improvements we continue to see in this basin contributed to production volumes surpassing our guidance while keeping capital expenditures below forecasted levels,&#8221; said Rick Muncrief, president and CEO of Devon Energy.
&#8220;Looking ahead to the remainder of 2024 and into 2025, we enhanced the quality and depth of our asset portfolio with the recent acquisition of Grayson Mill Energy. This transaction marks a major milestone, increasing our operating scale and strengthening our outlook for the fourth quarter and beyond.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/24/11/41759387/bigbear-ai-stock-drops-after-worse-than-expected-q3-revenue-details">BigBear.ai Stock Drops After Worse-Than-Expected Q3 Revenue: Details</a>
Outlook: Devon raised its production forecast for the fourth quarter to a range of 811,000 to 830,000 barrels of oil equivalent per day. The company now expects the midpoint of its capital requirements to be $950 million in the fourth quarter, which includes $150 million of incremental capital requirements related to the Williston Basin acquisition.
Management will hold a conference call to further discuss these results at 11 a.m. ET on Wednesday. 
DVN Price Action: <a href="http://benzinga.com/quote/dvn">Devon Energy shares</a> initially traded up above the $40.50 level on the report before pulling back. The stock was down 0.23% after hours at $39.25 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Earnings

Guidance

After-Hours Center

Devon Energy Q3 Earnings: EPS Beat, Production Forecast Raise And More

2024 Presidential Election Polls Close In The Following States: OH, NC, WV

Trump Media & Technology Shares Move Higher On Volume Over Past Few Minutes

As the election certification process is underway, House Speaker Mike Johnson (R-La.) has urged for calmness amidst the heightened emotions and misinformation.
What Happened: In response to EWTN News reporter Mark Irons&#8217; query about his role in certifying the election results, affirmed his commitment to uphold the Constitution and ensure a free and fair election, <a href="https://thehill.com/homenews/campaign/4973098-mike-johnson-certifying-election-results-everybody-needs-to-calm-down/">reported</a> The Hill.
Johnson played a pivotal role in the 2020 election, supporting former President Donald Trump&#8217;s challenge against President Joe Biden&#8217;s victory. He was key in formulating the legal argument for contesting Trump&#8217;s defeat, accusing some states of changing voting rules during the COVID-19 pandemic in violation of the Constitution.
See Also: <a href="https://www.benzinga.com/news/24/11/41701311/scaramucci-says-trump-should-be-taken-into-custody-over-alleged-threat-against-liz-cheney?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Scaramucci Says Trump &#8216;Should Be Taken Into Custody&#8217; Over Alleged Threat Against Liz Cheney</a>
Johnson downplayed claims of attempts to overturn the election results as &#8220;hyperbole and madness&#8221;. He also criticized the media for overreacting to Trump&#8217;s &#8220;secret&#8221; mentioned at his Madison Square Garden rally, which Johnson clarified was a voter mobilization effort, not a hidden agenda.
&#8220;There's just too much emotion, too much misinformation out there. Everybody needs to calm down,&#8221; said Johnson.
Johnson urged citizens to perform their &#8220;civic duty&#8221; and participate in an &#8220;American election&#8221; that will be certified. He expressed confidence in a second Trump term and a Republican-controlled Congress, stating the election will be &#8220;too big to rig&#8221;.
&#8220;I think President Trump's going to win today and I think we're going to win the Senate and the House, so we're excited,&#8221; said the House Speaker.
At the time of writing, polls were beginning to close across the U.S. with AP declaring Indian, Kentucky for Trump, and Vermont for Kamala Harris.
Why It Matters: Johnson&#8217;s call for calm comes amidst a backdrop of a <a href="https://www.benzinga.com/general/politics/24/11/41728436/trump-vs-harris-2024-election-deadlocked-final-emerson-poll-shows-one-candidate-with-small-edge-">closely contested</a> 2024 U.S. presidential election between Vice President Harris and former President Trump. As per a Benzinga report, the election remains one of the closest in history, with a tight race expected between the two candidates.
Several election-related legal battles have <a href="https://www.benzinga.com/government/24/11/41761179/supreme-court-could-step-in-if-2024-election-remains-deadlocked">already reached the Supreme Court</a>, including a decision to allow Virginia&#8217;s removal of over 1,600 voters from its rolls and rulings affecting candidates and voters in battleground states. This has raised concerns over the potential involvement of the U.S. Supreme Court in determining the outcome of the election.
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Mike Johnson Urges Calm On Result Certification: The Election Is 'Too Big To Rig'

2024 Presidential Election Polls Close In The Following States: GA, IN, KY, SC, VA, VT

Seaport Global analyst Tom Curran initiates coverage on First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Neutral rating.

Initiation

Analyst Ratings

FSLR

Seaport Global Initiates Coverage On First Solar with Neutral Rating

Candel gains FDA orphan status for brain tumor candidate

Candel Therapeutics to join Russell 3000 Index

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Let me be clear: investing in <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a> isn&rsquo;t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance. Investing in A-rated biotech stocks offers high return potential if they make significant advancements in health care.



Biotech stocks represent companies that are involved in the research and development of drugs, therapies and medical devices. They include companies that work in fields such as genomics, biopharmaceuticals, bioinformatics and medical diagnostics.



A-rated biotech stocks are highly coveted because they are at the forefront &mdash; or in the midst of &mdash; groundbreaking innovation. 



A biotech company that wins regulatory approval for a new drug can see a huge increase in stock price, providing lucrative returns to investors and billions of dollars in annual profit for the company.



But remember &mdash; bringing a drug to market costs a lot of money. Biotech stocks must absorb high research and development costs through laboratory research, preclinical trials and multiple phases of clinical trials. 



It can take years to bring a drug to market, or even to get it in front of the Food and Drug Administration for approval. Any setback can derail the drug pipeline and cause the stock price to collapse.



By using the Portfolio Grader, we can identify A-rated biotech stocks based on analyst sentiment, earnings performance, growth and stock buying momentum. If you want to try your hand in the biotech sector, these A-rated biotech stocks are a good place to start.



<h2>Eli Lilly &amp; Co. (LLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/lly_eli_lilly_1600-300x169.png" alt="Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals XI"><div>Source: Jonathan Weiss / Shutterstock.com</div></div>Eli Lilly &amp; Co. (NYSE:<a href="https://investorplace.com/stock-quotes/lly-stock-quote/">LLY</a>) can arguably be considered the best biotech stock on the market right now. 



The Indianapolis-based biotech company is set to make billions of dollars a year through its weight-loss treatment drug. And now there&rsquo;s yet another catalyst that is sending LLY stock higher.



First, let&rsquo;s talk about Zepbound, which is Lilly&rsquo;s FDA-approved drug to help people lose weight. The injectable drug won FDA approval in November 2023, so Lilly is just getting started on a long run of profits. About 42% of the U.S. population is obese and the window for Lilly to profit from Zepbound is huge.



The drug in Zepbound, tirzepatide, is also used in another highly successful Lilly product called Mounjaro, which is used to treat type 2 diabetes.



The drugs are so popular that Lilly is&nbsp;<a href="https://investor.lilly.com/news-releases/news-release-details/lilly-increases-manufacturing-investment-9-billion-newest">increasing its investment</a>&nbsp;in its Indiana manufacturing facility from $3.7 billion to $9 billion to increase the production of tirzepatide and other pipeline products.



And now Lilly is set to score big on another treatment. An FDA panel voted unanimously in favor of the company&rsquo;s <a href="https://investorplace.com/2024/06/eli-lilly-stock-hits-new-52-week-high-as-fda-panel-recommends-alzheimers-drug/">donanemab&nbsp;</a>drug, which would be used to treat Alzheimer&rsquo;s. The full FDA still needs to give final approval, but the unanimous recommendation of its panel is a very good sign.



LLY stock reached a new 52-week high on the news. The stock is now up 48% on the year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Lexaria Bioscience (LEXX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2-300x169.jpg" alt="A close-up concept image of a tiny glass vial with a strand of DNA in it. best biotech stocks"><div>Source: Shutterstock</div></div>Lexaria Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/lexx-stock-quote/">LEXX</a>) is a much different biotech company than Lilly. But the company has its own wins and is worthy of its status as an A-rated biotech stock.



Lexaria developed DehydraTECH, which is a drug delivery technology that improves the way active pharmaceutical ingredients enter the bloodstream.



Lexaria says its platform promotes healthier delivery methods and increases the effectiveness of drugs that are delivered by tablets, capsules and oral suspensions.



Any drug delivery system that makes medications more effective and more tolerable to patients is going to be popular in the biotech field. 



The DehydraTECH platform increases the absorption of the drug into a patient and helps the medication take effect faster. It also reduces the need for sugar-filled products because it can mask the taste of medications.



While R&amp;D costs are still outweighing profits, there&rsquo;s good reason to be bullish on LEXX stock, which is already up 159% this year. It gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Novo Nordisk (NVO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/nvo-stock-300x169.jpg" alt="Novo Nordisk logo on a corporate building"><div>Source: joreks / Shutterstock.com</div></div>Novo Nordisk (NYSE:<a href="https://investorplace.com/stock-quotes/nvo-stock-quote/">NVO</a>) has some of the same catalysts are work that are pushing LLY stock higher. 



The European company has an injectable weight loss drug of its own, called Wegovy. Wegovy was approved in 2021 by U.S. regulators to treat weight loss and recently as also approved for treatment in the U.K.



Wegovy&rsquo;s popularity has led to shortages in some pharmacies as Novo Nordisk struggles to keep up with demand. The company&rsquo;s running its manufacturing operations 24 hours a day to meet demand.



Novo Nordisk has another huge drug on the market, Ozempic, which is a treatment for type 2 diabetes.



<a href="https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168508">Earnings for the first quarter</a> included days of 65.3 billion Danish kroner ($9.46 billion), up 22% from a year ago. Operating profit was up 27%, and net profits were up 29%.



Novo Nordisk reported earnings per share of 5.68 Danish kroner (85 cents per share), which was up 29% from a year ago.



NVO stock is up 38% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Ocugen (OCGN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/ocgn1600-2-300x169.png" alt="Person holding cellphone with webpage of US biopharmaceutical company Ocugen Inc (OCGN) on screen in front of logo Focus on center of phone display"><div>Source: Wirestock Creators / Shutterstock.com</div></div>Ocugen (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocgn-stock-quote/">OCGN</a>) is a small biotech company based in Pennsylvania. With a market capitalization of less than $400 million, Ocugen is working on developing and commercializing gene and cell therapies.



The company has a breakthrough modifier gene therapy platform that has the potential to treat multiple retinal disease with a single product, which could be highly lucrative if brought to market.



The company has <a href="https://ocugen.com/therapeutic-areas/">multiple retinal products</a> in various phases of testing in an effort to treat hard-to-treat eye disease. 



It also has a treatment in Phase 3 testing to treat knee cartilage damage and ideally help prevent osteoarthritis, and it has started on a potential inhaled vaccine that would help prevent Covid-19.



The company&rsquo;s stock will get a boost later this month when it joins the Russell 3000, an inclusion that should improve the trading volume as funds that track the index purchase OCGN shares.



The company reported <a href="https://ir.ocugen.com/news-releases/news-release-details/ocugen-provides-business-update-first-quarter-2024-financial">cash and cash equivalents</a> of $25.4 million at the end of the first quarter, with total operating expenses for the quarter of $13.2 million. 



Bringing a drug to market is expensive. But since it has FDA approval for Phase 3 trials for its retinal treatment, the company is on the verge of bringing to market a treatment that affects an estimated 300,000 people in the U.S. and Europe.



OCGN stock still trades for less than $2 per share, but probably won&rsquo;t be that low for long. The stock is up 154% so far in 2024 and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Candel Therapeutics (CADL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600-300x169.png" alt="Light blue pills on white background. Pharmaceutical industry, medical treatment, presciption drugs concept. Digital 3D render., biotech stocks, big pharma. EVAX stock"><div>Source: Hernan E. Schmidt / Shutterstock.com</div></div>Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) is a Massachusetts that works with viral immunotherapies in an effort to treat cancer. 



Its treatment platform includes combining an anti-tumor component and an immune-stimulatory component to attack malignant cells.



The company developed two clinical stage investigational viral immunotherapies designed to produce an individualized cancer response, based on genetically modified adenovirus and herpes simplex virus gene constructs, respectively.



It currently has several drug candidates in Phase 2 and Phase 3 trials, including treatments for prostate, lung and pancreatic cancer. Like Ocugen, Candel is also joining the Russell 3000 this year.



The company had <a href="https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-reports-first-quarter-2024-financial-results">cash and cash equivalents</a> of $25.7 million at the end of the first quarter, which is says will be sufficient to fund operations into the fourth quarter. R&amp;D expenses in the first quarter were only $4.1 million, while general and administrative expenses were only $3.8 million.



CADL stock soared since April and is now up more than 400% this year. It gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Teva Pharmaceutical (TEVA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/teva1600a-300x169.jpg" alt="Opioids Made TEVA Stock Untouchable But Things Seem to be Changing"><div>Source: JHVEPhoto / Shutterstock.com</div></div>Teva Pharmaceutical (NYSE:<a href="https://investorplace.com/stock-quotes/teva-stock-quote/">TEVA</a>) is a leading manufacturer of generic pharmaceuticals. Once a company loses exclusivity in a drug several years after bringing it to market, any drug manufacturer can offer a generic equivalent that can be sold for less than the name-brand drug. That&rsquo;s where Teva comes in.



Teva says nearly 200 million people around the world use drugs that it manufacturers, with production sites in 53 locations spanning 33 countries. The company says its generic equivalents help patients save more than $40 billion a year in health care costs.



One of its <a href="https://investorplace.com/2024/02/teva-stock-pops-4-as-teva-receives-fda-approval/">newest treatments</a> is with a strategic partner, Alvotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/alvo-stock-quote/">ALVO</a>), which won FDA approval for an injectable drug to be used as an alternative to Humira, which is a prescription drug to treat rheumatoid arthritis. 



Humira is made by AbbVie (NYSE:<a href="https://investorplace.com/stock-quotes/abbv-stock-quote/">ABBV</a>), and was one of the biggest pharmaceutical products in the world last year with $12.2 billion in sales.



Revenue for the first quarter was $1.72 billion, up from $1.67 billion a year ago. The company reported profits of $350 million, up from $338 million in the first quarter of 2023.



TEVA stock is up 64% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>GSK (GSK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/gsk-stock-1-300x169.jpg" alt="A GlaxoSmithKline (GSK) office in London."><div>Source: Willy Barton / Shutterstock.com</div></div>GSK (NYSE:<a href="https://investorplace.com/stock-quotes/gsk-stock-quote/">GSK</a>), also known as GlaxoSmithKline, is a British biotech company that focuses on making treatments for infectious diseases, HIV, immunology and respiratory conditions and cancer.



Its top drugs include Calpol, which treats cold systems in infants; Ceftum, an antibiotic, and Neosporin, which in cream form treats skin pain, itches and wounds.



The company has more than 70 vaccine candidates and specialty medications in clinical development, with 18 in Phase 3 testing.



Sales in the first quarter were 7.4 billion British pounds ($9.46 billion), up 10% from a year ago. Profits were 2.4 billion British pounds, up 27% from a year ago.



GSK stock is up 11% this year and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



On the date of publication, Louis Navellier had long positions in NVO and LLY. Louis Navellier did not have (either directly or indirectly) any other positions in the securities mentioned in this article.



The InvestorPlace Research Staff member primarily responsible for this article did not hold (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-a-rated-biotech-stocks-worth-betting-on-in-june/">7 A-Rated Biotech Stocks Worth Betting on in June</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 A-Rated Biotech Stocks Worth Betting on in June

Candel Therapeutics: Innovative Cancer Therapies, But Short Cash Runway

3 Biotech Names With Potential Catalysts By Year End

Candel Therapeutics GAAP EPS of -$0.74

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) just reported results for the second quarter of 2024.<ul><li>Candel Therapeutics reported earnings per share of -74 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/cadl-stock-earnings-candel-therapeutics-for-q2-of-2024/">CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024

Buy Stocks Now, Here Are 3 Categories

An announcement from Candel Therapeutics ( ($CADL) ) is now available. Candel Therapeutics has reported promising results from its ongoing phase 1b...

Candel Therapeutics Advances in Cancer Treatment Trials

Candel Therapeutics (CADL) announced preclinical results and therapeutic potential of CAN-3110 in the Ras-Raf pathway altered melanoma model. The d...

Comments

Candel Therapeutics

Candel Therapeutics (CADL) 옵션

Candel Therapeutics (NASDAQ:CADL) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌